Literature DB >> 28283574

Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions.

Suneet Shukla1, Biebele Abel1, Eduardo E Chufan1, Suresh V Ambudkar2.   

Abstract

P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolysis to export many structurally dissimilar hydrophobic and amphipathic compounds, including anticancer drugs from cells. Several structural studies on purified P-gp have been reported, but only limited and sometimes conflicting information is available on ligand interactions with the isolated transporter in a dodecyl-maltoside detergent environment. In this report we compared the biochemical properties of P-gp in native membranes, detergent micelles, and when reconstituted in artificial membranes. We found that the modulators zosuquidar, tariquidar, and elacridar stimulated the ATPase activity of purified human or mouse P-gp in a detergent micelle environment. In contrast, these drugs inhibited ATPase activity in native membranes or in proteoliposomes, with IC50 values in the 10-40 nm range. Similarly, a 30-150-fold decrease in the apparent affinity for verapamil and cyclic peptide inhibitor QZ59-SSS was observed in detergent micelles compared with native or artificial membranes. Together, these findings demonstrate that the high-affinity site is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment. The ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity. We, therefore, recommend studying structural and functional aspects of ligand interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipathic or hydrophobic substrates in a detergent-free native or artificial membrane environment.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC transporter; ATP hydrolysis; P-glycoprotein; detergent micelles; docking; drug resistance; molecular modeling; multidrug transporter; nanodiscs; proteoliposomes

Mesh:

Substances:

Year:  2017        PMID: 28283574      PMCID: PMC5409473          DOI: 10.1074/jbc.M116.771634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.

Authors:  Tasha K Ritchie; Hyewon Kwon; William M Atkins
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.

Authors:  N Lerner-Marmarosh; K Gimi; I L Urbatsch; P Gros; A E Senior
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

Review 4.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

5.  Structure of an antibacterial peptide ATP-binding cassette transporter in a novel outward occluded state.

Authors:  Hassanul G Choudhury; Zhen Tong; Indran Mathavan; Yanyan Li; So Iwata; Séverine Zirah; Sylvie Rebuffat; Hendrik W van Veen; Konstantinos Beis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-11       Impact factor: 11.205

6.  Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.

Authors:  Eduardo E Chufan; Khyati Kapoor; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2015-12-11       Impact factor: 5.858

7.  Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates.

Authors:  K M Kerr; Z E Sauna; S V Ambudkar
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

8.  Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.

Authors:  M Ramachandra; S V Ambudkar; D Chen; C A Hrycyna; S Dey; M M Gottesman; I Pastan
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

9.  Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pump.

Authors:  Julien Marcoux; Sheila C Wang; Argyris Politis; Eamonn Reading; Jerome Ma; Philip C Biggin; Min Zhou; Houchao Tao; Qinghai Zhang; Geoffrey Chang; Nina Morgner; Carol V Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  MDR1 causes resistance to the antitumour drug miltefosine.

Authors:  M Rybczynska; R Liu; P Lu; F J Sharom; E Steinfels; A D Pietro; M Spitaler; H Grunicke; J Hofmann
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  16 in total

1.  Structural insight into substrate and inhibitor discrimination by human P-glycoprotein.

Authors:  Amer Alam; Julia Kowal; Eugenia Broude; Igor Roninson; Kaspar P Locher
Journal:  Science       Date:  2019-02-15       Impact factor: 47.728

2.  ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.

Authors:  Sabrina Lusvarghi; Suresh V Ambudkar
Journal:  Biochem J       Date:  2019-12-19       Impact factor: 3.857

Review 3.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

4.  Large-scale purification of functional human P-glycoprotein (ABCB1).

Authors:  Krishnamachary Nandigama; Sabrina Lusvarghi; Suneet Shukla; Suresh V Ambudkar
Journal:  Protein Expr Purif       Date:  2019-03-06       Impact factor: 1.650

5.  Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.

Authors:  Reza Dastvan; Smriti Mishra; Yelena B Peskova; Robert K Nakamoto; Hassane S Mchaourab
Journal:  Science       Date:  2019-05-17       Impact factor: 47.728

6.  Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.

Authors:  Shahrooz Vahedi; Eduardo E Chufan; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2017-07-17       Impact factor: 5.858

7.  Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.

Authors:  Martin Prescher; Sander H J Smits; Lutz Schmitt
Journal:  J Lipid Res       Date:  2020-09-11       Impact factor: 5.922

8.  Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.

Authors:  Maria E Zoghbi; Leo Mok; Douglas J Swartz; Anukriti Singh; Gregory A Fendley; Ina L Urbatsch; Guillermo A Altenberg
Journal:  J Biol Chem       Date:  2017-10-09       Impact factor: 5.157

9.  Active participation of membrane lipids in inhibition of multidrug transporter P-glycoprotein.

Authors:  Karan Kapoor; Shashank Pant; Emad Tajkhorshid
Journal:  Chem Sci       Date:  2021-04-09       Impact factor: 9.825

10.  Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1.

Authors:  Amer Alam; Raphael Küng; Julia Kowal; Robert A McLeod; Nina Tremp; Eugenia V Broude; Igor B Roninson; Henning Stahlberg; Kaspar P Locher
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.